|
|
| Issue Open | Aug 7, 2017 |
| Issue Close | Aug 10, 2017 |
| IPO Price | ₹72 |
| Face Value | ₹10 |
| IPO Size | ₹14.23 Cr |
| Listing At | NSE SME |
| IPO Lot Size | 1600 |
May 6, 2022 9:49:00 AM
New foreign shareholders in LIC will not only improve capital adequacy and financial flexibility but also enhance's LIC's operational and distribution efficiences by pushing for a wider online ...
Publish by : IndiatimesApr 20, 2022 5:33:00 PM
Ahmedabad (Gujarat) [India], April 20 (ANI/PNN): Ahmedabad-based Sankalp Life Care, a leading manufacturer of nutraceuticals, and Mumbai-headquartered Vaishali Pharma Ltd., a leading manufacturer and ...
Publish by : Big News Network.comMay 14, 2022 3:30:00 AM
The Half Yearly Results page of Vaishali Pharma Ltd. presents the key Half Yearly result items, its comparison with the sector peers and its previous 5 Half Yearly Results.
Publish by : IndiatimesApr 20, 2022 4:57:00 PM
Ahmedabad (Gujarat) [India], April 20 (ANI/PNN): Ahmedabad-based Sankalp Life Care, a leading manufacturer of nutraceuticals, and Mumbai-headquartered Vaishali Pharma, a leading manufacturer and ...
Publish by : Big News Network.comMay 13, 2022 3:30:00 AM
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex ...
Publish by : InvestingMay 13, 2022 2:56:00 PM
<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px ...
Publish by : money.rediffMay 19, 2022 9:21:00 AM
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Publish by : Investing.comMay 16, 2022 12:42:00 PM
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Publish by : InvestingMay 9, 2022 3:30:00 AM
© 2007-2022 Fusion Media Limited. All Rights Reserved. Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the ...
Publish by : Investing.comApr 5, 2022 3:30:00 AM
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex ...
Publish by : InvestingVaishali Pharma IPO Listing Date
› Listing Date: Tuesday, August 22, 2017
› NSE Symbol: VAISHALI
› ISIN: INE972X01014
› Issue Price: Rs 72 Per Equity Share
› Face Value: Rs 10 Per Equity Share
The issue of Vaishali Pharma Ltd opens on Aug 07, 2017 and closes for subscription on Aug 10, 2017. The equity shares of the company to be list at NSE Emerge. The price band for the issue has been fixed at Rs 71 at lower level and Rs 72 at upper level.
Vaishali Pharma Ltd is entering in the capital market with an IPO of 1,976,000 Equity Shares of Rs 10. The price band for the issue has been fixed at Rs 71 at lower level and Rs 72 at upper level.
Vaishali Pharma Ltd is a pharmaceutical company engaged in pharmaceutical formulations, APIs, surgical products, veterinary supplements, herbal & nutraceutical products. They are operating both in domestic and export markets. They have also established office in the Vietnam. At present they are supplying in around 10 countries.
The issue opens on Aug 07, 2017 and closes for subscription on Aug 10, 2017. The equity shares of the company to be list at NSE Emerge.
The Vaishali Pharma IPO is proposed to open on Aug 7, 2017. The IPO application ends on Aug 10, 2017.
Retail investors can apply in the retail or non-institutional investor category from Aug 7, 2017 to Aug 10, 2017. The Vaishali Pharma IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Vaishali Pharma IPO will open for subscription on Aug 7, 2017. The public issue will close on Aug 10, 2017.
Useful Articles
|
|
